BIO-key receives Nasdaq notice for delayed 10-Q filing; delisting hearing set for June 16

BIO KEY INTERNATIONAL INC

Received Nasdaq notice of non-compliance with Listing Rule 5250(c)(1) for failure to timely file Q1 2026 Form 10-Q.
This is an additional basis for delisting; previously appealed Nasdaq's May 6 determination to suspend trading.
Hearing before Nasdaq Hearing Panel scheduled for June 16, 2026.
No assurance that the Panel will grant continued listing or that compliance can be regained.

Featured in Daily 8-K Digest

Selected #2 for 2026-06-10. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.